{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:15:59Z","timestamp":1793304959826,"version":"4.5.0"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Coronavirus disease 2019 (COVID-19) convalescent plasma (CCP) use between October and December 2020 was characterized using the National Inpatient Sample database. CCP was administered in 18.0% of COVID-19-associated hospitalizations and was strongly associated with older age and increased disease severity. There were disparities in the receipt of CCP by race and ethnicity, geography, and insurance.<\/jats:p>","DOI":"10.1093\/cid\/ciad185","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T20:26:25Z","timestamp":1680121585000},"page":"237-241","source":"Crossref","is-referenced-by-count":3,"title":["Coronavirus Disease 2019 Convalescent Plasma Utilization in the United States: Data From the National Inpatient Sample"],"prefix":"10.1093","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8181-9517","authenticated-orcid":false,"given":"Evan M","family":"Bloch","sequence":"first","affiliation":[{"name":"Division of Transfusion Medicine, Department of Pathology, Johns Hopkins University , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchika","family":"Goel","sequence":"additional","affiliation":[{"name":"Division of Transfusion Medicine, Department of Pathology, Johns Hopkins University , Baltimore, Maryland , USA"},{"name":"Simmons Cancer Institute at Southern Illinois University , Springfield, Illinois , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianming","family":"Zhu","sequence":"additional","affiliation":[{"name":"Division of Transfusion Medicine, Department of Pathology, Johns Hopkins University , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eshan U","family":"Patel","sequence":"additional","affiliation":[{"name":"Division of Transfusion Medicine, Department of Pathology, Johns Hopkins University , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shmuel","family":"Shoham","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A","family":"Gebo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Casadevall","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron A R","family":"Tobian","sequence":"additional","affiliation":[{"name":"Division of Transfusion Medicine, Department of Pathology, Johns Hopkins University , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"key":"2023072620380666300_ciad185-B1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003872","article-title":"Access to and safety of COVID-19 convalescent plasma in the United States expanded access program: a national registry study","volume":"18","author":"Senefeld","year":"2021","journal-title":"PLoS Med"},{"key":"2023072620380666300_ciad185-B2","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.7326\/M22-1079","article-title":"Clinical practice guidelines from the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 convalescent plasma","volume":"175","author":"Estcourt","year":"2022","journal-title":"Ann Intern Med"},{"key":"2023072620380666300_ciad185-B3","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJMoa2031893","article-title":"Convalescent plasma antibody levels and the risk of death from COVID-19","volume":"384","author":"Joyner","year":"2021","journal-title":"New England Journal of Medicine"},{"key":"2023072620380666300_ciad185-B4","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa2033700","article-title":"Early high-titer plasma therapy to prevent severe Covid-19 in older adults","volume":"384","author":"Libster","year":"2021","journal-title":"N Engl J Med"},{"key":"2023072620380666300_ciad185-B5","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1056\/NEJMoa2119657","article-title":"Early outpatient treatment for Covid-19 with convalescent plasma","volume":"386","author":"Sullivan","year":"2022","journal-title":"N Engl J Med"},{"key":"2023072620380666300_ciad185-B6","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.7326\/M22-2329","article-title":"The fast and the furious: chasing a clinical niche for COVID-19 convalescent plasma","volume":"175","author":"Baker","year":"2022","journal-title":"Ann Intern Med"},{"key":"2023072620380666300_ciad185-B7","article-title":"Covid-19: Black people and other minorities are hardest hit in US","volume":"369:","author":"Dyer","year":"2020","journal-title":"BMJ"},{"key":"2023072620380666300_ciad185-B8","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2020.6548","article-title":"COVID-19 and African Americans","volume":"323","author":"Yancy","year":"2020","journal-title":"JAMA"},{"key":"2023072620380666300_ciad185-B9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.15585\/mmwr.mm7103e1","article-title":"Racial and ethnic disparities in receipt of medications for treatment of COVID-19\u2014United States, march 2020\u2013August 2021","volume":"71","author":"Wiltz","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023072620380666300_ciad185-B10","doi-asserted-by":"crossref","first-page":"e151518","DOI":"10.1172\/jci.insight.151518","article-title":"Pharmacokinetics of high-titer anti-SARS-CoV-2 human convalescent plasma in high-risk children","volume":"7","author":"Gordon","year":"2022","journal-title":"JCI Insight"},{"key":"2023072620380666300_ciad185-B11","author":"JHU"},{"key":"2023072620380666300_ciad185-B12","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/trf.16871","article-title":"How do I implement an outpatient program for the administration of convalescent plasma for COVID-19?","volume":"62","author":"Bloch","year":"2022","journal-title":"Transfusion"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciad185\/50310950\/ciad185.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/77\/2\/237\/50968879\/ciad185.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/77\/2\/237\/50968879\/ciad185.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T21:18:54Z","timestamp":1690406334000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/77\/2\/237\/7092828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":12,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,3,29]]},"published-print":{"date-parts":[[2023,7,26]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciad185","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7,15]]},"published":{"date-parts":[[2023,3,29]]}}}